EnSite X EP cardiac mapping System: cost and payments to doctors
What Medicare Part D paid pharmacies for EnSite X EP cardiac mapping System, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Abbott?
Abbott reported the most payments naming EnSite X EP cardiac mapping System. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $56K
- Providers
- 0
- Transactions
- 4
- Average per transaction
- $14,000
The per-transaction average — $14,000 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Abbott | $56,000 | 100.0% |
Other products from Abbott
The company that reported the most payments naming EnSite X EP cardiac mapping System also reports against these.
- PROCLAIM$14,811,931
- MitraClip$9,886,390
- FREESTYLE LIBRE 3$9,531,015
- AVEIR$8,443,593
- AMPLATZER AMULET$8,425,850
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$7,557,545
- CARDIOMEMS$6,528,879
- ENSITE PRECISION$5,038,193
- ENSITE$4,842,840
- Supera peripheral stent system$4,838,270